Clinical Trial Update: Melphalan, Peripheral Stem Cell Transplantation, and Interleukin-2 Followed by Interferon Alfa in Treating Patients With Advanced Multiple Myeloma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating melphalan with peripheral stem cell transplantation followed by interleukin-2 and interferon alfa in patients with advanced multiple …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Interferon Alfa (interferon alfa)
• Interleukin-2 (interleukin-2)
• Melphalan (Melphalan)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Refractory Multiple Myeloma, Stage I Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2017-05-16